Company / R&D per Share
OPKO HEALTH, INC. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.16
FY2025
5-year range
$0.12 / $0.16
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#193 of 208
Health Care
What the data says
Among 208 Health Care companies, OPKO HEALTH, INC. is in the bottom 7% for r&d per share. R&D per Share returned to growth in FY2025 after 2 years of decline, reaching $0.16.
Based on SEC 10-K filings.
0.16 in FY2025 with a 5-year CAGR of -5.8%.
Improved from $0.13 to $0.16 over the past 4 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- -5.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 208This company $0.16 Sector average $12.19
▼
-98.6% below sector average
Key checks
Key Insights
- Ranks #193 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2016.
- Lowest r&d per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.08 (distress zone, below 1.8 threshold)
- Negative profit margin: -7.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.16 | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.12 | -10.6% |
| FY2021 | $0.13 | -42.1% |
| FY2020 | $0.22 | +5.8% |
| FY2019 | $0.21 | +2.9% |
| FY2018 | $0.20 | -20.9% |
| FY2017 | $0.26 | -4.0% |
| FY2016 | $0.27 | -3.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026